{"id":"W4411535590","doi":"10.1080/14796678.2025.2513805","title":"Long-term safety and effectiveness of evinacumab in people with homozygous familial hypercholesterolemia: a plain language summary","year":2025,"lang":"en","type":"article","venue":"Future Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université du Québec à Chicoutimi","funders":"Servier; Novo Nordisk; Argenx; Amryt Pharma; Fresenius Medical Care North America; Amarin Corporation; Mylan; Ionis Pharmaceuticals; Abbott Laboratories; Regeneron Pharmaceuticals; Esperion Therapeutics; Ultragenyx Pharmaceutical; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Amgen; Vifor Pharma; Pfizer; Daiichi Sankyo Europe; Silence Therapeutics; Kowa Company; Sanofi","keywords":"Medicine; Familial hypercholesterolemia; Term (time); Plain language; Pediatrics; Internal medicine; Intensive care medicine; Linguistics; Cholesterol","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008135104,0.000180484,0.001083765,0.0001663363,0.00003986473,0.000003977599,0.00007392668,0.0002714456,0.000002034804],"category_scores_gemma":[0.00004538207,0.0001328314,0.0001540645,0.0002791553,0.0001083936,0.00003252749,0.00007038548,0.0003742369,0.000001055891],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001316916,"about_ca_system_score_gemma":0.0002093549,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002198352,"about_ca_topic_score_gemma":0.0005035731,"domain_scores_codex":[0.9984753,0.0005199207,0.0002312343,0.0003583563,0.0001477051,0.0002674956],"domain_scores_gemma":[0.9992211,0.0001310973,0.00004106314,0.0004708552,0.000065465,0.00007041571],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005036163,0.00005769976,0.961475,0.002850893,0.0005714766,0.001318991,0.0004881663,0.00003507042,0.001779287,0.0002039015,0.00005160862,0.02613178],"study_design_scores_gemma":[0.005002243,0.0004475751,0.9913493,0.0006004835,0.0002039649,0.001057431,0.0003924762,0.000002756266,0.0002406439,0.000006372229,0.0005886979,0.0001080179],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9857323,0.01082361,0.000849559,0.0001802443,0.000262746,0.0008963725,0.00002703205,0.00002728281,0.00120091],"genre_scores_gemma":[0.9981687,0.0009754912,0.00007498325,0.0001593253,0.0003960036,0.00006067977,0.00008797246,0.00001685419,0.00005996648],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02987437,"threshold_uncertainty_score":0.5416706,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.003289234119944993,"score_gpt":0.2430604286347147,"score_spread":0.2397711945147697,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}